Share Price and Basic Stock Data
Last Updated: February 6, 2026, 4:26 pm
| PEG Ratio | 0.42 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Frontline Corporation Ltd operates in the transport sector with a focus on road transport, recording a market capitalization of ₹16.5 Cr and a current share price of ₹33.0. The company has demonstrated steady growth in sales, which stood at ₹77 Cr for the fiscal year ending March 2023, up from ₹72 Cr in the previous year. This upward trend continued with trailing twelve-month (TTM) sales reaching ₹111 Cr. Quarterly sales figures also reflect this growth, with sales increasing from ₹15.56 Cr in September 2022 to ₹22.84 Cr in June 2023. However, the revenue growth has not been linear; there were fluctuations, particularly a dip in March 2023, where sales fell to ₹20.56 Cr. The company has been able to maintain a positive trajectory in the subsequent quarters, suggesting a recovery and potential stabilization in operations as sales for September 2023 recorded ₹21.27 Cr. Overall, the revenue trends indicate a resilient business in a competitive sector.
Profitability and Efficiency Metrics
The profitability of Frontline Corporation is reflected in its operating profit margin (OPM), which stood at 2.51%, indicating a modest profitability level. However, the company faced challenges, as evidenced by a negative operating profit of ₹0.92 Cr in March 2023. Despite this, the operating profit improved in subsequent quarters, reaching ₹0.33 Cr in September 2023. The net profit for the fiscal year ending March 2023 was ₹3 Cr, with earnings per share (EPS) of ₹5.44, which rose to ₹5.80 for the fiscal year ending March 2025, indicating an overall positive trend. The interest coverage ratio (ICR) was reported at 7.88x, suggesting a strong ability to meet interest obligations. Nevertheless, the return on equity (ROE) of 14.6% and return on capital employed (ROCE) of 4.73% indicate that while profitability exists, there is room for improvement in efficiency metrics compared to industry standards.
Balance Sheet Strength and Financial Ratios
Frontline Corporation’s balance sheet reveals a total borrowing of ₹56 Cr against reserves of ₹12 Cr, indicating a relatively high leverage situation with a total debt-to-equity ratio of 3.72x. This level of debt may raise concerns among investors, particularly in a sector known for its volatility. The company’s current ratio stands at 0.51, suggesting potential liquidity challenges, particularly against typical sector benchmarks, which generally range around 1.2 to 2.0. However, the interest coverage ratio of 7.88x demonstrates that the company can comfortably cover its interest expenses. The book value per share has increased to ₹30.92 in March 2025 from ₹14.36 in March 2021, reflecting a strengthening of shareholder equity over time. These financial ratios highlight both the risks associated with high leverage and the potential for growth if managed effectively.
Shareholding Pattern and Investor Confidence
As of December 2025, the shareholding pattern reveals that promoters hold 47.18% of the stake while public shareholders account for 52.80%. This distribution indicates a strong public interest in the company, with a growing number of shareholders rising to 1,407. The promoter holding has seen a gradual decline from 48.63% in March 2023, which may suggest dilution of control but also reflects an increasing confidence from public investors. The stability in public shareholding, despite fluctuations in promoter stakes, indicates robust investor confidence. However, the lack of foreign institutional investors (FIIs) and domestic institutional investors (DIIs) might signal a hesitance among larger institutional players, which could affect liquidity and market perception. The increasing shareholder base is a positive indicator of interest and confidence in the company’s future prospects.
Outlook, Risks, and Final Insight
Looking ahead, Frontline Corporation faces both opportunities and challenges. The consistent growth in sales and improvement in profit margins suggests potential for sustained performance. However, the high debt levels and low current ratio present significant risks, particularly in an economic environment sensitive to interest rate changes and fuel price fluctuations. Additionally, operational efficiency remains a concern, as indicated by the modest ROCE and OPM figures. The company must focus on enhancing operational efficiencies to improve profitability and reduce leverage. The outlook could be favorable if Frontline Corporation capitalizes on its growth trajectory while addressing its balance sheet weaknesses. A strategic focus on cost management and operational improvements could lead to enhanced shareholder value. Conversely, failure to manage debt levels and operational inefficiencies may hinder growth and investor confidence.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Frontline Corporation Ltd | 15.3 Cr. | 30.6 | 61.5/26.1 | 5.64 | 33.0 | 0.00 % | 4.73 % | 14.6 % | 10.0 |
| Coastal Roadways Ltd | 14.0 Cr. | 33.6 | 42.9/29.0 | 10.2 | 58.6 | 0.00 % | 9.25 % | 6.35 % | 10.0 |
| Balurghat Technologies Ltd | 26.7 Cr. | 14.7 | 25.4/12.6 | 381 | 9.03 | 0.00 % | 13.0 % | 12.7 % | 10.0 |
| ABC India Ltd | 36.0 Cr. | 66.5 | 118/65.2 | 29.3 | 100 | 0.75 % | 6.82 % | 4.15 % | 10.0 |
| Transport Corporation of India Ltd (TCI) | 8,180 Cr. | 1,063 | 1,299/875 | 18.3 | 312 | 0.85 % | 20.5 % | 19.8 % | 2.00 |
| Industry Average | 2,943.00 Cr | 145.17 | 75.16 | 119.06 | 0.18% | 12.03% | 10.77% | 8.56 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 15.56 | 19.60 | 20.56 | 22.84 | 21.27 | 21.18 | 22.56 | 24.86 | 25.26 | 25.34 | 28.50 | 31.49 | 25.86 |
| Expenses | 15.00 | 18.64 | 21.48 | 22.82 | 20.94 | 21.02 | 23.02 | 24.43 | 24.58 | 24.56 | 28.14 | 30.70 | 25.21 |
| Operating Profit | 0.56 | 0.96 | -0.92 | 0.02 | 0.33 | 0.16 | -0.46 | 0.43 | 0.68 | 0.78 | 0.36 | 0.79 | 0.65 |
| OPM % | 3.60% | 4.90% | -4.47% | 0.09% | 1.55% | 0.76% | -2.04% | 1.73% | 2.69% | 3.08% | 1.26% | 2.51% | 2.51% |
| Other Income | 0.70 | 0.73 | 2.22 | 0.73 | 0.79 | 0.87 | 0.96 | 0.78 | 1.07 | 0.81 | 1.70 | 0.73 | 0.81 |
| Interest | 0.01 | 0.01 | 0.08 | 0.01 | 0.01 | 0.02 | 0.18 | 0.21 | 0.20 | 0.18 | 0.25 | 0.22 | 0.20 |
| Depreciation | 0.39 | 0.41 | 0.42 | 0.42 | 0.42 | 0.38 | 0.38 | 0.47 | 0.49 | 0.49 | 0.74 | 0.56 | 0.54 |
| Profit before tax | 0.86 | 1.27 | 0.80 | 0.32 | 0.69 | 0.63 | -0.06 | 0.53 | 1.06 | 0.92 | 1.07 | 0.74 | 0.72 |
| Tax % | 23.26% | 24.41% | 21.25% | 59.38% | 37.68% | 34.92% | -533.33% | 28.30% | 13.21% | 23.91% | 17.76% | 22.97% | 25.00% |
| Net Profit | 0.67 | 0.97 | 0.63 | 0.14 | 0.42 | 0.41 | 0.25 | 0.39 | 0.91 | 0.71 | 0.88 | 0.57 | 0.55 |
| EPS in Rs | 1.34 | 1.94 | 1.26 | 0.28 | 0.84 | 0.82 | 0.50 | 0.78 | 1.82 | 1.42 | 1.76 | 1.14 | 1.10 |
Last Updated: December 26, 2025, 10:38 pm
Below is a detailed analysis of the quarterly data for Frontline Corporation Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 25.86 Cr.. The value appears to be declining and may need further review. It has decreased from 31.49 Cr. (Jun 2025) to 25.86 Cr., marking a decrease of 5.63 Cr..
- For Expenses, as of Sep 2025, the value is 25.21 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 30.70 Cr. (Jun 2025) to 25.21 Cr., marking a decrease of 5.49 Cr..
- For Operating Profit, as of Sep 2025, the value is 0.65 Cr.. The value appears to be declining and may need further review. It has decreased from 0.79 Cr. (Jun 2025) to 0.65 Cr., marking a decrease of 0.14 Cr..
- For OPM %, as of Sep 2025, the value is 2.51%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 2.51%.
- For Other Income, as of Sep 2025, the value is 0.81 Cr.. The value appears strong and on an upward trend. It has increased from 0.73 Cr. (Jun 2025) to 0.81 Cr., marking an increase of 0.08 Cr..
- For Interest, as of Sep 2025, the value is 0.20 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.22 Cr. (Jun 2025) to 0.20 Cr., marking a decrease of 0.02 Cr..
- For Depreciation, as of Sep 2025, the value is 0.54 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.56 Cr. (Jun 2025) to 0.54 Cr., marking a decrease of 0.02 Cr..
- For Profit before tax, as of Sep 2025, the value is 0.72 Cr.. The value appears to be declining and may need further review. It has decreased from 0.74 Cr. (Jun 2025) to 0.72 Cr., marking a decrease of 0.02 Cr..
- For Tax %, as of Sep 2025, the value is 25.00%. The value appears to be increasing, which may not be favorable. It has increased from 22.97% (Jun 2025) to 25.00%, marking an increase of 2.03%.
- For Net Profit, as of Sep 2025, the value is 0.55 Cr.. The value appears to be declining and may need further review. It has decreased from 0.57 Cr. (Jun 2025) to 0.55 Cr., marking a decrease of 0.02 Cr..
- For EPS in Rs, as of Sep 2025, the value is 1.10. The value appears to be declining and may need further review. It has decreased from 1.14 (Jun 2025) to 1.10, marking a decrease of 0.04.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 3:43 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 42 | 38 | 38 | 43 | 44 | 47 | 48 | 59 | 72 | 77 | 88 | 104 | 111 |
| Expenses | 40 | 36 | 38 | 46 | 44 | 47 | 50 | 58 | 71 | 76 | 88 | 102 | 109 |
| Operating Profit | 2 | 1 | 0 | -2 | -0 | -1 | -2 | 1 | 0 | 1 | 0 | 2 | 3 |
| OPM % | 5% | 3% | 1% | -5% | -0% | -1% | -4% | 1% | 0% | 1% | 0% | 2% | 2% |
| Other Income | 4 | 3 | 1 | 10 | 4 | 3 | 3 | 3 | 4 | 4 | 3 | 4 | 4 |
| Interest | 6 | 5 | 5 | 5 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 1 |
| Depreciation | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Profit before tax | -1 | -2 | -5 | 1 | 2 | -1 | -1 | 1 | 2 | 4 | 2 | 4 | 3 |
| Tax % | -87% | -11% | -18% | 33% | 17% | -35% | -16% | 12% | 21% | 23% | 22% | 19% | |
| Net Profit | -0 | -2 | -4 | 1 | 2 | -0 | -1 | 1 | 1 | 3 | 1 | 3 | 3 |
| EPS in Rs | -0.34 | -3.66 | -8.50 | 1.70 | 3.84 | -0.66 | -1.98 | 2.30 | 2.90 | 5.42 | 2.44 | 5.78 | 5.42 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -100.00% | 125.00% | 100.00% | -100.00% | 200.00% | 0.00% | 200.00% | -66.67% | 200.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | 225.00% | -25.00% | -200.00% | 300.00% | -200.00% | 200.00% | -266.67% | 266.67% |
Frontline Corporation Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2015-2016 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 16% |
| 3 Years: | 13% |
| TTM: | 23% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 32% |
| 3 Years: | 12% |
| TTM: | 109% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 34% |
| 3 Years: | 40% |
| 1 Year: | -3% |
| Return on Equity | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 15% |
| 3 Years: | 14% |
| Last Year: | 15% |
Last Updated: September 5, 2025, 3:30 pm
Balance Sheet
Last Updated: December 4, 2025, 2:53 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Reserves | 7 | 5 | 1 | 0 | 2 | 2 | 1 | 2 | 4 | 6 | 8 | 10 | 12 |
| Borrowings | 38 | 45 | 39 | 51 | 54 | 53 | 53 | 52 | 49 | 49 | 57 | 57 | 56 |
| Other Liabilities | 24 | 19 | 32 | 17 | 15 | 15 | 10 | 6 | 6 | 6 | 8 | 9 | 10 |
| Total Liabilities | 74 | 73 | 77 | 73 | 77 | 75 | 68 | 65 | 63 | 66 | 77 | 82 | 82 |
| Fixed Assets | 27 | 26 | 28 | 32 | 35 | 33 | 34 | 32 | 31 | 30 | 34 | 35 | 34 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 0 | 1 |
| Investments | 7 | 7 | 7 | 0 | 0 | 0 | 0 | 1 | 1 | 2 | 1 | 0 | 2 |
| Other Assets | 40 | 40 | 42 | 40 | 41 | 41 | 35 | 32 | 32 | 34 | 40 | 46 | 46 |
| Total Assets | 74 | 73 | 77 | 73 | 77 | 75 | 68 | 65 | 63 | 66 | 77 | 82 | 82 |
Below is a detailed analysis of the balance sheet data for Frontline Corporation Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 5.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 5.00 Cr..
- For Reserves, as of Sep 2025, the value is 12.00 Cr.. The value appears strong and on an upward trend. It has increased from 10.00 Cr. (Mar 2025) to 12.00 Cr., marking an increase of 2.00 Cr..
- For Borrowings, as of Sep 2025, the value is 56.00 Cr.. The value appears to be improving (decreasing). However, Borrowings exceed Reserves, which may signal higher financial risk. It has decreased from 57.00 Cr. (Mar 2025) to 56.00 Cr., marking a decrease of 1.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 10.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 9.00 Cr. (Mar 2025) to 10.00 Cr., marking an increase of 1.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 82.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 82.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 34.00 Cr.. The value appears to be declining and may need further review. It has decreased from 35.00 Cr. (Mar 2025) to 34.00 Cr., marking a decrease of 1.00 Cr..
- For CWIP, as of Sep 2025, the value is 1.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2025) to 1.00 Cr., marking an increase of 1.00 Cr..
- For Investments, as of Sep 2025, the value is 2.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2025) to 2.00 Cr., marking an increase of 2.00 Cr..
- For Other Assets, as of Sep 2025, the value is 46.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 46.00 Cr..
- For Total Assets, as of Sep 2025, the value is 82.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 82.00 Cr..
However, the Borrowings (56.00 Cr.) are higher than the Reserves (12.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -36.00 | -44.00 | -39.00 | -53.00 | -54.00 | -54.00 | -55.00 | -51.00 | -49.00 | -48.00 | -57.00 | -55.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 75 | 74 | 66 | 77 | 82 | 66 | 57 | 57 | 42 | 39 | 38 | 39 |
| Inventory Days | 169 | 213 | 208 | 130 | 141 | 142 | 88 | 40 | 35 | 47 | 48 | 53 |
| Days Payable | 242 | 200 | 64 | 203 | 216 | 192 | 100 | 38 | 24 | 24 | 28 | 32 |
| Cash Conversion Cycle | 1 | 86 | 209 | 4 | 7 | 16 | 45 | 59 | 53 | 61 | 59 | 60 |
| Working Capital Days | -291 | -365 | -348 | -273 | -246 | -237 | -252 | -204 | -161 | -147 | -136 | -108 |
| ROCE % | 4% | 5% | 0% | 11% | 4% | -0% | -1% | 3% | 4% | 4% | 2% | 5% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 5.80 | 2.44 | 5.44 | 2.91 | 2.30 |
| Diluted EPS (Rs.) | 5.80 | 2.44 | 5.44 | 2.91 | 2.30 |
| Cash EPS (Rs.) | 10.21 | 5.67 | 8.65 | 6.43 | 6.34 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 30.92 | 25.11 | 22.77 | 17.25 | 14.36 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 30.92 | 25.11 | 22.77 | 17.25 | 14.36 |
| Revenue From Operations / Share (Rs.) | 208.85 | 176.49 | 154.04 | 144.14 | 117.74 |
| PBDIT / Share (Rs.) | 13.28 | 6.83 | 10.51 | 7.78 | 7.51 |
| PBIT / Share (Rs.) | 8.87 | 3.59 | 7.30 | 4.26 | 3.47 |
| PBT / Share (Rs.) | 7.18 | 3.15 | 7.09 | 3.70 | 2.62 |
| Net Profit / Share (Rs.) | 5.80 | 2.44 | 5.44 | 2.91 | 2.30 |
| PBDIT Margin (%) | 6.35 | 3.86 | 6.82 | 5.39 | 6.37 |
| PBIT Margin (%) | 4.24 | 2.03 | 4.74 | 2.95 | 2.94 |
| PBT Margin (%) | 3.44 | 1.78 | 4.59 | 2.56 | 2.22 |
| Net Profit Margin (%) | 2.77 | 1.38 | 3.53 | 2.02 | 1.95 |
| Return on Networth / Equity (%) | 18.77 | 9.72 | 23.90 | 16.88 | 16.04 |
| Return on Capital Employeed (%) | 19.51 | 8.43 | 29.19 | 23.00 | 17.80 |
| Return On Assets (%) | 3.52 | 1.57 | 4.07 | 2.28 | 1.77 |
| Long Term Debt / Equity (X) | 0.47 | 0.69 | 0.09 | 0.07 | 0.35 |
| Total Debt / Equity (X) | 3.72 | 4.56 | 4.34 | 5.69 | 7.08 |
| Asset Turnover Ratio (%) | 1.31 | 1.22 | 1.18 | 1.12 | 0.88 |
| Current Ratio (X) | 0.51 | 0.54 | 0.48 | 0.44 | 0.44 |
| Quick Ratio (X) | 0.33 | 0.38 | 0.35 | 0.35 | 0.36 |
| Inventory Turnover Ratio (X) | 10.79 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 7.88 | 15.24 | 48.34 | 13.75 | 8.86 |
| Interest Coverage Ratio (Post Tax) (X) | 4.44 | 6.45 | 26.04 | 6.15 | 3.72 |
| Enterprise Value (Cr.) | 76.12 | 75.35 | 60.46 | 61.41 | 54.17 |
| EV / Net Operating Revenue (X) | 0.73 | 0.85 | 0.78 | 0.85 | 0.92 |
| EV / EBITDA (X) | 11.52 | 22.18 | 11.56 | 15.87 | 14.49 |
| MarketCap / Net Operating Revenue (X) | 0.19 | 0.21 | 0.15 | 0.18 | 0.08 |
| Price / BV (X) | 1.33 | 1.55 | 1.07 | 1.57 | 0.67 |
| Price / Net Operating Revenue (X) | 0.19 | 0.21 | 0.15 | 0.18 | 0.08 |
| EarningsYield | 0.14 | 0.06 | 0.22 | 0.10 | 0.23 |
After reviewing the key financial ratios for Frontline Corporation Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 5.80. This value is within the healthy range. It has increased from 2.44 (Mar 24) to 5.80, marking an increase of 3.36.
- For Diluted EPS (Rs.), as of Mar 25, the value is 5.80. This value is within the healthy range. It has increased from 2.44 (Mar 24) to 5.80, marking an increase of 3.36.
- For Cash EPS (Rs.), as of Mar 25, the value is 10.21. This value is within the healthy range. It has increased from 5.67 (Mar 24) to 10.21, marking an increase of 4.54.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 30.92. It has increased from 25.11 (Mar 24) to 30.92, marking an increase of 5.81.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 30.92. It has increased from 25.11 (Mar 24) to 30.92, marking an increase of 5.81.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 208.85. It has increased from 176.49 (Mar 24) to 208.85, marking an increase of 32.36.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 13.28. This value is within the healthy range. It has increased from 6.83 (Mar 24) to 13.28, marking an increase of 6.45.
- For PBIT / Share (Rs.), as of Mar 25, the value is 8.87. This value is within the healthy range. It has increased from 3.59 (Mar 24) to 8.87, marking an increase of 5.28.
- For PBT / Share (Rs.), as of Mar 25, the value is 7.18. This value is within the healthy range. It has increased from 3.15 (Mar 24) to 7.18, marking an increase of 4.03.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 5.80. This value is within the healthy range. It has increased from 2.44 (Mar 24) to 5.80, marking an increase of 3.36.
- For PBDIT Margin (%), as of Mar 25, the value is 6.35. This value is below the healthy minimum of 10. It has increased from 3.86 (Mar 24) to 6.35, marking an increase of 2.49.
- For PBIT Margin (%), as of Mar 25, the value is 4.24. This value is below the healthy minimum of 10. It has increased from 2.03 (Mar 24) to 4.24, marking an increase of 2.21.
- For PBT Margin (%), as of Mar 25, the value is 3.44. This value is below the healthy minimum of 10. It has increased from 1.78 (Mar 24) to 3.44, marking an increase of 1.66.
- For Net Profit Margin (%), as of Mar 25, the value is 2.77. This value is below the healthy minimum of 5. It has increased from 1.38 (Mar 24) to 2.77, marking an increase of 1.39.
- For Return on Networth / Equity (%), as of Mar 25, the value is 18.77. This value is within the healthy range. It has increased from 9.72 (Mar 24) to 18.77, marking an increase of 9.05.
- For Return on Capital Employeed (%), as of Mar 25, the value is 19.51. This value is within the healthy range. It has increased from 8.43 (Mar 24) to 19.51, marking an increase of 11.08.
- For Return On Assets (%), as of Mar 25, the value is 3.52. This value is below the healthy minimum of 5. It has increased from 1.57 (Mar 24) to 3.52, marking an increase of 1.95.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.47. This value is within the healthy range. It has decreased from 0.69 (Mar 24) to 0.47, marking a decrease of 0.22.
- For Total Debt / Equity (X), as of Mar 25, the value is 3.72. This value exceeds the healthy maximum of 1. It has decreased from 4.56 (Mar 24) to 3.72, marking a decrease of 0.84.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.31. It has increased from 1.22 (Mar 24) to 1.31, marking an increase of 0.09.
- For Current Ratio (X), as of Mar 25, the value is 0.51. This value is below the healthy minimum of 1.5. It has decreased from 0.54 (Mar 24) to 0.51, marking a decrease of 0.03.
- For Quick Ratio (X), as of Mar 25, the value is 0.33. This value is below the healthy minimum of 1. It has decreased from 0.38 (Mar 24) to 0.33, marking a decrease of 0.05.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 10.79. This value exceeds the healthy maximum of 8. It has increased from 0.00 (Mar 24) to 10.79, marking an increase of 10.79.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 7.88. This value is within the healthy range. It has decreased from 15.24 (Mar 24) to 7.88, marking a decrease of 7.36.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4.44. This value is within the healthy range. It has decreased from 6.45 (Mar 24) to 4.44, marking a decrease of 2.01.
- For Enterprise Value (Cr.), as of Mar 25, the value is 76.12. It has increased from 75.35 (Mar 24) to 76.12, marking an increase of 0.77.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.73. This value is below the healthy minimum of 1. It has decreased from 0.85 (Mar 24) to 0.73, marking a decrease of 0.12.
- For EV / EBITDA (X), as of Mar 25, the value is 11.52. This value is within the healthy range. It has decreased from 22.18 (Mar 24) to 11.52, marking a decrease of 10.66.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.19. This value is below the healthy minimum of 1. It has decreased from 0.21 (Mar 24) to 0.19, marking a decrease of 0.02.
- For Price / BV (X), as of Mar 25, the value is 1.33. This value is within the healthy range. It has decreased from 1.55 (Mar 24) to 1.33, marking a decrease of 0.22.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.19. This value is below the healthy minimum of 1. It has decreased from 0.21 (Mar 24) to 0.19, marking a decrease of 0.02.
- For EarningsYield, as of Mar 25, the value is 0.14. This value is below the healthy minimum of 5. It has increased from 0.06 (Mar 24) to 0.14, marking an increase of 0.08.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Frontline Corporation Ltd:
- Net Profit Margin: 2.77%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 19.51% (Industry Average ROCE: 12.03%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 18.77% (Industry Average ROE: 10.77%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 4.44
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.33
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 5.64 (Industry average Stock P/E: 75.16)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 3.72
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 2.77%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Transport - Road | 4, B.B.D Bag (East), Stephen House, Kolkata West Bengal 700001 | frontlinecorplimited@gmail.com http://www.frontlinecorporation.org |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ram Prasad Agarwal | Chairman & Director |
| Mr. Pawan Kumar Agarwal | Managing Director |
| Mr. Narayan Prasad Agarwal | Director |
| Mr. Saurabh Jhunjhunwala | Director |
| Mrs. Dipika Pradeep Soni | Independent Woman Director |
| Mr. Dipen Ashit Dalal | Independent Director |
| Ms. Aarefa Kutub Kapasi | Independent Woman Director |
| Mrs. Ummay Amen Mashraqi | Independent Woman Director |
FAQ
What is the intrinsic value of Frontline Corporation Ltd?
Frontline Corporation Ltd's intrinsic value (as of 07 February 2026) is ₹25.12 which is 17.91% lower the current market price of ₹30.60, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹15.3 Cr. market cap, FY2025-2026 high/low of ₹61.5/26.1, reserves of ₹12 Cr, and liabilities of ₹82 Cr.
What is the Market Cap of Frontline Corporation Ltd?
The Market Cap of Frontline Corporation Ltd is 15.3 Cr..
What is the current Stock Price of Frontline Corporation Ltd as on 07 February 2026?
The current stock price of Frontline Corporation Ltd as on 07 February 2026 is ₹30.6.
What is the High / Low of Frontline Corporation Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Frontline Corporation Ltd stocks is ₹61.5/26.1.
What is the Stock P/E of Frontline Corporation Ltd?
The Stock P/E of Frontline Corporation Ltd is 5.64.
What is the Book Value of Frontline Corporation Ltd?
The Book Value of Frontline Corporation Ltd is 33.0.
What is the Dividend Yield of Frontline Corporation Ltd?
The Dividend Yield of Frontline Corporation Ltd is 0.00 %.
What is the ROCE of Frontline Corporation Ltd?
The ROCE of Frontline Corporation Ltd is 4.73 %.
What is the ROE of Frontline Corporation Ltd?
The ROE of Frontline Corporation Ltd is 14.6 %.
What is the Face Value of Frontline Corporation Ltd?
The Face Value of Frontline Corporation Ltd is 10.0.